Hyperphosphatemia Treatment Global Market Report 2022 – By Product (Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Others), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, Online stores) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : May 2022 | SKU CODE : h1559 | Delivery Time: 2-3 business days | Format :


The hyperphosphatemia treatment market consists of sales of hyperphosphatemia products by entities (organization, partnerships, and sole traders), which are used to restrict phosphate intake and the administration of phosphate-binding antacids like carbonate. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood, it can cause chronic renal disorder, hypoparathyroidism, and metabolic or respiratory acidosis.

The main products in the hyperphosphatemia treatment market are sevelamer, calcium-based phosphate binders, iron-based phosphate binders, lanthanum carbonate, and others. The sevelamer market consists of sales of sevelamer products by entities (organization, partnerships, and sole traders) that refers to phosphate binding medication used for treatment of hyperphosphatemia in patients with chronic and kidney diseases. The hyperphosphatemia treatment are distributed through hospital pharmacies, retail pharmacies, and online stores.

The global hyperphosphatemia treatment market size is expected to grow from $3.22 billion in 2021 to $3.57 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The global hyperphosphatemia treatment market size is expected to grow to $5.5 billion in 2026 at a CAGR of 11.5%.

Increasing chronic diseases among patients is driving the growth of the hyperphosphatemia treatment market. Chronic diseases are non-communicable and require long-term care. A vast majority of chronic diseases can be categorized as cardiovascular diseases, chronic kidney disease, chronic respiratory conditions, hyperparathyroidism, diabetes, and cancer. According to the world health organization (WHO), chronic disease prevalence is predicted to increase by 57% by the year 2020. According to the United States Renal Data System they estimated that there are more than 300,000 patients with end-stage renal disease in the United States. There had been an increase in Hyperphosphatemia among patients with end-stage renal disease (ESRD), thus contributing to increase in demand for hyperphosphatemia treatment or drugs.

The increasing research & development activities are a key trend in the hyperphosphatemia treatment market. The company in hyperphosphatemia treatment are focusing on R&D activities for the development of innovative therapies for the treatment of renal diseases and related chronic conditions. For instance, in May 2021, Alebund Pharmaceuticals, a Shanghai-based biopharmaceutical company raised $60 million in a Series B round to accelerate its development activities of innovative drugs and solutions for the treatment of renal diseases including hyperphosphatemia.

In December 2020, Unicycive a US-based company that develops novel treatments across multiple therapeutic areas acquired Renazorb, for an undisclosed amount. This acquisition will helps Renazorb rapidly develop an alternate treatment for hyperphosphatemia supported an extended history of the utilization of lanthanum compounds for phosphate binding but with a potential to significantly enhance simple dosing and thereby improve patient adherence. Renazorb is a US-based company that's a non-aluminum, non-calcium, phosphate binder manufactured employing a patent-protected nanotechnology process.

Major players in the hyperphosphatemia treatment market are Sanofi, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Akebia Therapeutics, Inc, Vifor Pharma Management Ltd., Lupin Limited, Ardelyx, Inc, Unicycive Therapeutics Inc, Keryx Biopharmaceuticals, Zeria Pharmaceutical, Fresenius Medical Care, Shire, Ultragenyx Pharmaceutical, Inc, Sun Pharmaceutical Industries, Ltd, Akebia Therapeutics Inc, and AMAG Pharmaceuticals, Inc.

North America was the largest region in the hyperphosphatemia treatment market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global hyperphosphatemia treatment market during the forecast period. The regions covered in the global hyperphosphatemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the global hyperphosphatemia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global hyperphosphatemia treatment market is segmented -

1) By Product: Sevelamer, Calcium-Based Phosphate Binders, Iron-Based Phosphate Binders, Lanthanum Carbonate, Others

2) By Distribution channel: Hospital Pharmacy, Retail Pharmacy, Online Stores

    Table Of Contents

    1. Executive Summary

    2. Hyperphosphatemia Treatment Market Characteristics

    3. Hyperphosphatemia Treatment Market Trends And Strategies

    4. Impact Of COVID-19 On Hyperphosphatemia Treatment

    5. Hyperphosphatemia Treatment Market Size And Growth

    5.1. Global Hyperphosphatemia Treatment Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Hyperphosphatemia Treatment Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Hyperphosphatemia Treatment Market Segmentation

    6.1. Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Sevelamer

    Calcium-Based Phosphate Binders

    Iron-Based Phosphate Binders

    Lanthanum Carbonate

    Others

    6.2. Global Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital pharmacy

    Retail Pharmacy

    Online stores

    7. Hyperphosphatemia Treatment Market Regional And Country Analysis

    7.1. Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Hyperphosphatemia Treatment Market

    8.1. Asia-Pacific Hyperphosphatemia Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Hyperphosphatemia Treatment Market

    9.1. China Hyperphosphatemia Treatment Market Overview

    9.2. China Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Hyperphosphatemia Treatment Market

    10.1. India Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Hyperphosphatemia Treatment Market

    11.1. Japan Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Hyperphosphatemia Treatment Market

    12.1. Australia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Hyperphosphatemia Treatment Market

    13.1. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Hyperphosphatemia Treatment Market

    14.1. South Korea Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Hyperphosphatemia Treatment Market

    15.1. Western Europe Hyperphosphatemia Treatment Market Overview

    15.2. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Hyperphosphatemia Treatment Market

    16.1. UK Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Hyperphosphatemia Treatment Market

    17.1. Germany Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Hyperphosphatemia Treatment Market

    18.4. France Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Hyperphosphatemia Treatment Market

    19.1. Eastern Europe Hyperphosphatemia Treatment Market Overview

    19.2. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Hyperphosphatemia Treatment Market

    20.1. Russia Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Hyperphosphatemia Treatment Market

    21.1. North America Hyperphosphatemia Treatment Market Overview

    21.2. North America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Hyperphosphatemia Treatment Market

    22.1. USA Hyperphosphatemia Treatment Market Overview

    22.2. USA Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Hyperphosphatemia Treatment Market

    23.1. South America Hyperphosphatemia Treatment Market Overview

    23.2. South America Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Hyperphosphatemia Treatment Market

    24.1. Brazil Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Hyperphosphatemia Treatment Market

    25.1. Middle East Hyperphosphatemia Treatment Market Overview

    25.2. Middle East Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Hyperphosphatemia Treatment Market

    26.1. Africa Hyperphosphatemia Treatment Market Overview

    26.2. Africa Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Hyperphosphatemia Treatment Market Competitive Landscape And Company Profiles

    27.1. Hyperphosphatemia Treatment Market Competitive Landscape

    27.2. Hyperphosphatemia Treatment Market Company Profiles

    27.2.1. Sanofi

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Takeda Pharmaceutical Company Limited

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Astellas Pharma Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Akebia Therapeutics, Inc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Vifor Pharma Management Ltd.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Hyperphosphatemia Treatment Market

    29. Hyperphosphatemia Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: India, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: India, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Japan, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Japan, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Australia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Australia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: UK, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: UK, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Germany, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Germany, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: France, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: France, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Russia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Russia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: North America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: North America, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: USA, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: USA, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: South America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: South America, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Africa, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Africa, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Sanofi Financial Performance
  • Table 46: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 47: Astellas Pharma Inc Financial Performance
  • Table 48: Akebia Therapeutics, Inc Financial Performance
  • Table 49: Vifor Pharma Management Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Hyperphosphatemia Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Hyperphosphatemia Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: China, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: India, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: India, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Japan, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: Japan, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Australia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Australia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Indonesia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: South Korea, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: Western Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: UK, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: UK, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Germany, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Germany, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: France, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: France, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: Eastern Europe, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Russia, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Russia, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: North America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: North America, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: USA, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: USA, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: South America, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: South America, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: Brazil, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Middle East, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Africa, Hyperphosphatemia Treatment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Africa, Hyperphosphatemia Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Sanofi Financial Performance
  • Figure 46: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 47: Astellas Pharma Inc Financial Performance
  • Figure 48: Akebia Therapeutics, Inc Financial Performance
  • Figure 49: Vifor Pharma Management Ltd. Financial Performance
Global Precision Medicine Market Size, Forecasts, And Opportunities – Includes Precision Medicine Market Share
Global Kidney Cancer Drugs Market Outlook, Opportunities And Strategies – Includes Kidney Cancer Drugs Market Size
Global Regenerative Medicine For Cartilage Market Outlook, Opportunities And Strategies – Includes Regenerative Medicine For Cartilage Market Size
Global Pegfilgrastim Biosimilars Market Size, Forecasts, And Opportunities – Includes Pegfilgrastim Biosimilars Market Share
Global Microbiome Market Outlook, Opportunities And Strategies – Includes Microbiome Market Trends
Global Regenerative Medicine Market Size, Forecasts, And Opportunities – Includes Regenerative Medicine Market Share
Global Multivitamin Capsules And Tablets Market Overview And Prospects – Multivitamin Capsule
Global Joint Pain Injections Market Growth Analysis And Indications – Includes Joint Pain Injections Market Size
Dialysis Devices And Equipment Global Market Report 2022 – By Product (Hemodialysis Devices, Peritoneal Dialysis Devices), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies) –Market Size, Trends, And Global Forecast 2022-2026
View Report
Gastrointestinal Devices Global Market Report 2022 – By Product Type (Gi Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Microbiome Global Market Report 2022 – By Type (Fecal Microbiota Transplantation (FMT), Microbiome drugs), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Technology (Genomics, Proteomics, Metabolomics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Endoscopy Devices And Equipment Global Market Report 2022 – By Product (Endoscope, Endoscopy Operative Devices , Endoscopy Visualization Systems), By End-User (Hospitals, Clinics), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology endoscopy, Neuroendoscopy, Gastrointestinal endoscopy, Obstetrics/gynecology endoscopy, ENT endoscopy) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Gastrointestinal Bleeding Treatment Devices Global Market Report 2022 – By Product (Endoscopic Thermal Devices), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Medication Adherence Global Market Report 2022 – By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology, Others), By Application (Hospital, Retail Pharmacies, Long-Term Care Facilities, Mail-Order Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Medical Equipment Maintenance Global Market Report 2022 – By Service Type (Preventive Maintenance, Corrective Maintenance, Operational Maintenance), By Device (Imaging Equipment, Endoscopic Devices, Surgical Instruments, Electro-Medical Equipment), By Technology (Multi-Vendor OEMs, Single-Vendor OEMs, Independent Service Organization, In-House Maintenance), By End User (Hospital, Diagnostic Imaging Centres, Dialysis Centres, Ambulatory Surgical Centres, Dental Clinics And Speciality Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Biosimilar Therapeutic Peptides Global Market Report 2022 – By Route Of Administration (Parenteral Route, Transdermal Route), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders), By Type (Innovative, Generic) – Market Size, Trends, And Global Forecast 2022-2026
View Report